Common pathological processes in Alzheimer disease and type 2 diabetes: a review
- PMID: 17920690
- DOI: 10.1016/j.brainresrev.2007.09.001
Common pathological processes in Alzheimer disease and type 2 diabetes: a review
Abstract
Alzheimer disease (AD) and type 2 diabetes mellitus (T2DM) are conditions that affect a large number of people in the industrialized countries. Both conditions are on the increase, and finding novel treatments to cure or prevent them are a major aim in research. Somewhat surprisingly, AD and T2DM share several molecular processes that underlie the respective degenerative developments. This review describes and discusses several of these shared biochemical and physiological pathways. Disturbances in insulin signalling appears to be the main common impairment that affects cell growth and differentiation, cellular repair mechanisms, energy metabolism, and glucose utilization. Insulin not only regulates blood sugar levels but also acts as a growth factor on all cells including neurons in the CNS. Impairment of insulin signalling therefore not only affects blood glucose levels but also causes numerous degenerative processes. Other growth factor signalling systems such as insulin growth factors (IGFs) and transforming growth factors (TGFs) also are affected in both conditions. Also, the misfolding of proteins plays an important role in both diseases, as does the aggregation of amyloid peptides and of hyperphosphorylated proteins. Furthermore, more general physiological processes such as angiopathic and cytotoxic developments, the induction of apoptosis, or of non-apoptotic cell death via production of free radicals greatly influence the progression of AD and T2DM. The increase of detailed knowledge of these common physiological processes open up the opportunities for treatments that can prevent or reduce the onset of AD as well as T2DM.
Similar articles
-
Diabetes as a risk factor for Alzheimer's disease: insulin signalling impairment in the brain as an alternative model of Alzheimer's disease.Biochem Soc Trans. 2011 Aug;39(4):891-7. doi: 10.1042/BST0390891. Biochem Soc Trans. 2011. PMID: 21787319
-
Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.Brain Res. 2008 Jun 5;1213:152-65. doi: 10.1016/j.brainres.2008.03.043. Epub 2008 Apr 1. Brain Res. 2008. PMID: 18455153
-
Role of the JNK-interacting protein 1/islet brain 1 in cell degeneration in Alzheimer disease and diabetes.Brain Res Bull. 2009 Oct 28;80(4-5):274-81. doi: 10.1016/j.brainresbull.2009.07.006. Epub 2009 Jul 16. Brain Res Bull. 2009. PMID: 19616077 Review.
-
The role of GLP-1 in neuronal activity and neurodegeneration.Vitam Horm. 2010;84:331-54. doi: 10.1016/B978-0-12-381517-0.00013-8. Vitam Horm. 2010. PMID: 21094907 Review.
-
Beta-cell function and mass in type 2 diabetes.Dan Med Bull. 2009 Aug;56(3):153-64. Dan Med Bull. 2009. PMID: 19728971
Cited by
-
Cognitive performance during senescence in untreated congenital isolated GH deficiency.Endocr Connect. 2023 Dec 21;13(1):e230401. doi: 10.1530/EC-23-0401. Print 2024 Jan 1. Endocr Connect. 2023. PMID: 38019109 Free PMC article.
-
Toward attention-based learning to predict the risk of brain degeneration with multimodal medical data.Front Neurosci. 2023 Jan 18;16:1043626. doi: 10.3389/fnins.2022.1043626. eCollection 2022. Front Neurosci. 2023. PMID: 36741058 Free PMC article.
-
Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.Drug Des Devel Ther. 2018 Nov 22;12:3999-4021. doi: 10.2147/DDDT.S173970. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30538427 Free PMC article. Review.
-
Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan.Alzheimers Dement (N Y). 2018 Apr 9;4:130-136. doi: 10.1016/j.trci.2018.03.002. eCollection 2018. Alzheimers Dement (N Y). 2018. PMID: 29955656 Free PMC article.
-
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link.Curr Neuropharmacol. 2021;19(1):78-91. doi: 10.2174/1570159X18666200309101750. Curr Neuropharmacol. 2021. PMID: 32148197 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical